2.365
Schlusskurs vom Vortag:
$2.40
Offen:
$2.42
24-Stunden-Volumen:
729.69K
Relative Volume:
0.38
Marktkapitalisierung:
$158.83M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.14M
KGV:
-7.7389
EPS:
-0.3056
Netto-Cashflow:
$-13.11M
1W Leistung:
+3.25%
1M Leistung:
-0.22%
6M Leistung:
-26.25%
1J Leistung:
+59.38%
Microbot Medical Inc Stock (MBOT) Company Profile
Firmenname
Microbot Medical Inc
Sektor
Telefon
908-938-5561
Adresse
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MBOT
Microbot Medical Inc
|
2.365 | 161.18M | 0 | -13.14M | -13.11M | -0.3056 |
|
ISRG
Intuitive Surgical Inc
|
451.71 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
154.99 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
74.52 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.77 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
223.75 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-12-03 | Eingeleitet | Roth Capital | Buy |
| 2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-31 | Eingeleitet | Ladenburg Thalmann | Buy |
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Dividend Watch: Is Microbot Medical Inc stock a value trap2026 Biggest Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Microbot Medical (MBOT) price target increased by 12.50% to 7.65 - MSN
Pullback Watch: Will Microbot Medical Inc outperform its industry peers2026 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn
[Form 4] Microbot Medical Inc. Insider Trading Activity - Stock Titan
Director at Microbot Medical (NASDAQ: MBOT) gets 10,000 options - Stock Titan
Director at Microbot Medical (NASDAQ: MBOT) awarded 10,000 stock options at $2.37 strike - Stock Titan
Director at Microbot Medical (NASDAQ: MBOT) granted 10,000 stock options at $2.37 - Stock Titan
Microbot Medical director granted 10,000 options | MBOT Insider Trading - Stock Titan
Microbot Medical highlights radiation reduction amid AMA policy shift - investing.com
Microbot Medical Inc. (MBOT) stock price, news, quote and history - Yahoo Finance Australia
MBOT Stock Price, Quote & Chart | MICROBOT MEDICAL INC (NASDAQ:MBOT) - ChartMill
Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Microbot Medical Inc Stock: Pioneering Robotics in Minimally Invasive Procedures for Future Medical - AD HOC NEWS
Microbot Medical (HAM:CY9D) PE Ratio : At Loss (As of Mar. 31, 2026) - gurufocus.com
Microbot Medical (HAM:CY9D) Net Income (Discontinued Operat - GuruFocus
Microbot Medical (HAM:CY9D) Degree of Operating Leverage : 0.00 (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) 3-1 Month Momentum % : 16.55% (As of Mar. 29, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) OCF Margin % : 0.00% (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) 6-Month Price Index : N/A (As of Mar. 28, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) Growth Rank : 0 (As of Mar. 28, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) Other Long Term Assets : €0.68 Mil (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Future 3-5Y EPS without NRI Gro - GuruFocus
Microbot Medical (HAM:CY9D) Price-to-Free-Cash-Flow : N/A (As of Mar. 28, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) PE Ratio (TTM) : At Loss (As of Apr. 01, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) Change In Prepaid Assets : €-0.78 Mil (TTM As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Change In Receivables : €0.00 Mil (TTM As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Capex-to-Operating-Income : 0.00 (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Long-Term Capital Lease Obligation : €0.49 Mil (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Payments of Debt : €0.00 Mil (TTM As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Quality Rank - GuruFocus
Microbot Medical (HAM:CY9D) Total Tax Payable : €0.00 Mil (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) 5-Year Yield-on-Cost % : 0.00 (As of Mar. 28, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) Gross-Profit-to-Asset % : 0.00% (As of Dec. 2025) - gurufocus.com
Microbot Medical (HAM:CY9D) 5-Year RORE % : -21.99% (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) PEG Ratio : 0.00 (As of Apr. 01, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) Moat Score : 4/10 (As of Mar. 28, 2026) - GuruFocus
Microbot Medical (HAM:CY9D) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2025) - gurufocus.com
Microbot Medical (HAM:CY9D) FFO per Share - gurufocus.com
Microbot Medical (HAM:CY9D) Dividends per Share : €0.00 (TTM As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Cyclically Adjusted Revenue per Share : €0.00 (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Goodwill : €0.00 Mil (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) PensionAndRetirementBenefit : €0.00 Mil (As of Dec. 2025) - gurufocus.com
Microbot Medical (HAM:CY9D) Earnings Yield % : N/A% (As of Mar. 28, 2026) - gurufocus.com
Microbot Medical (HAM:CY9D) 3-Year ROIIC % : -92.04% (As of Dec. 2025) - GuruFocus
HAM:CY9D Equity-to-Asset: 0.95 — 17% Above Median - GuruFocus
Microbot Medical (HAM:CY9D) Mohanram G-Score : N/A (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Predictability Rank - GuruFocus
Microbot Medical (HAM:CY9D) Sale Of Business : €0.00 Mil (TTM As of Dec. 2025) - gurufocus.com
Microbot Medical (HAM:CY9D) Short-Term Debt : €0.00 Mil (As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Other Financing : €0.00 Mil (TTM As of Dec. 2025) - GuruFocus
Microbot Medical (HAM:CY9D) Cyclically Adjusted Price-to-FC - gurufocus.com
Finanzdaten der Microbot Medical Inc-Aktie (MBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):